博济医药：卿芷软膏药物临床试验获批

Group 1 - The core point of the article is that Boji Pharmaceutical's subsidiary has received approval for a new traditional Chinese medicine formulation, "Qingzhi Ointment," from the National Medical Products Administration [1] - "Qingzhi Ointment" is classified as a Class 1 innovative traditional Chinese medicine and is designed to treat knee osteoarthritis with symptoms of wind-cold-dampness [1] - The formulation is based on traditional Chinese medicine principles and is not yet available in domestic or international markets [1]